Current status of morning blood pressure control and medication of hypertensive patients in Beijing

Chinese Journal of Cardiology

Volumn 41, Issue 7, 2013, Pages 587-589

  Wang, Yu Peng ^a   Li, Zhao Ping ^a   Bai, Qiong ^a   Chen, Shao Min ^a   Wang, Fang Fang ^a   Zhu, Dan ^a   Ren, Chuan ^a   Guo, Li Jun ^a   Gao, Wei ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Drug therapy; Hypertension; Hypotension, controlled

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FELODIPINE; NIFEDIPINE;

AMBULANCE; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOLOGY; CHINA; COHORT ANALYSIS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MORNING BLOOD PRESSURE CONTROL; TERTIARY CARE CENTER; TREATMENT OUTCOME;

ADULT; AGED; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; TIME FACTORS;

EID: 84891843243     PISSN: 02533758     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3758.2013.07.015     Document Type: Article

References (7)

1. 2011, 39: 579-615.
2. Kaneda R, Kario K, Hoshide S, et al. Morning blood pressure hyper-reactivity is an independent predictorfor hypertensive cardiac hypertrophyin a community-dwelling population. Am J Hypertens, 2005, 18: 1528-1533.
3. Kario K, Hoshide S, Shimizu M, et al. Effect of dosing time of angiotensin U receptor blockade titrated by self-measured blood pressure recordings on cardiorenal protection in hypertensives: the Japan MorningSurge-Target Organ Protection (JTOP) study. J Hypertens, 2010, 28: 1574-1583.
4. Marfella R, Gualdiero P, Siniscalchi M, et al. Morning blood pressure peak, QT intervals, and sympathetic activity in hypertensive patients. Hypertension, 2003, 41: 237-243.
5. Ju H L, Jang W B, Jung B P, et al. Morning hypertension in treated hypertensives: baseline characteristics and clinical implications. Korean Cire J, 2011, 41: 733-743.
6. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet, 2002, 360: 1903-1913.
7. Rothwell P M, Howard S C, Dolan E, et al. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol, 2010, 9: 469-480.